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Abstract
Purpose The aim of this study was to evaluate the results of
one- and two-stage revision total hip arthroplasties (THAs)
and to determine a rational surgical treatment strategy for
periprosthetic hip infections.
Methods We constructed a 12-point preoperative scoring sys-
tem to suggest either one- or two-stage revision THAs, based
on a retrospective analysis of 55 operative procedures. Pros-
thesis survival was analysed using the Kaplan-Meier method,
and the validity of the scoring system was evaluated using
receiver-operating characteristic curves.
Results At the end point of implant removal due to recurrent
infection, the ten year survival rates were 94 and 87% for one-
and two-stage revision THAs, respectively. One-stage revi-
sion THA was recommended for patients scoring >9 points.
The risk of recurrent infection in patients scoring 4 points was
83 %. The sensitivity and specificity of a cut-off value of 4
points, determined by the scoring system, were 83 and 100 %,
respectively.
Conclusions The novel pre-operative scoring system was
useful for the management of periprosthetic hip infections.
Keywords Infection . Total hip arthroplasty . One-stage
revision . Two-stage revision . Scoring system
Introduction
Treatments for periprosthetic hip infections remain controver-
sial and are particularly challenging because most patients
require implant removal. In North America, the gold standard
treatment for periprosthetic hip infection is two-stage revision
total hip arthroplasty (THA). In contrast, in Europe, one-stage
revision THA, which includes replacement of the prosthesis
during the same surgical procedure, is often preferred. This is
likely because one-stage revision THA usually employs an
antibiotic-loaded acrylic cement (ALAC) [1], and for over a
decade, the North American trend has been towards the use of
‘cementless’ techniques. According to some meta-analyses, the
infection control rate in two-stage revision THAs, usingALAC,
was 88–93 %, whereas that for one-stage revision THAs, also
with ALAC, was 82–86 % [2–5]. On the other hand, without
ALAC, infection control was achieved in 82–91% of two-stage
revision THA cases and in 56–59 % of one-stage revision
THAs [2–5]. The two-stage revision THA is safe, but has the
disadvantages of requiring a second operation and having
higher associated costs. Currently, there are algorithms and
staging systems for periprosthetic hip infections [6–10], so it
may be common for surgeons to employ one- or two-stage
revision THA as the situation demands. However, a scoring
system is not available to definitively determine the appropriate
surgical strategy for patients with periprosthetic hip infections.
We performed one- and two-stage revision THAs for
periprosthetic hip infection, according to various published
criteria [6, 7, 9–12]. Here, we attempted to set up a scoring
system for the pre-operative evaluation of one- and two-stage
revision THAs, based on a retrospective analysis of 55 cases.
The aim of this study was to report the scoring system and to
determine a rational surgical treatment strategy. The hypothe-
sis of the study was that a scoring system would facilitate
better management of periprosthetic hip infections.
Patients and methods
Between February 2001 and December 2011, 68 consecutive
revision THAs were performed at our institution for
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periprosthetic hip infections. One-stage revision THAs were
performed on 21 hips; two-stage revision THAs were per-
formed on 47 hips. The two-stage revision THAs included six
multiple-stage revision THAs that required ≥two debride-
ments and a single implantation. Periprosthetic hip infection
or healing was evaluated according to the criteria of Giulieri
et al. [13]. Infection was diagnosed if a sinus tract was present
and communicating with the joint space or if at least two of the
following criteria were met: (1) a positive bacterial culture
from at least one intra-operative tissue specimen or the joint
aspirate, (2) the presence of neutrophils in the tissue speci-
mens, (3) clinical and laboratory signs of infection or (4)
radiological signs of infection. Healing was defined as the
lack of clinical signs and symptoms of infection, a C-reactive
protein (CRP) level <10 mg/l or an erythrocyte sedimentation
rate <20 mm/h and the absence of radiological signs of infec-
tion at the follow-up visit >24 months after the first revision.
Therefore, a successful case was defined as the absence of
infection at the >24-month, post-revision follow-up visit;
failure was defined as implant removal due to recurrent infec-
tion. Of the total number of patients undergoing revision
THAs, 13 returned to their original referring hospital and were
lost to follow-up. Based on telephone consultations, the 13
patients did not undergo additional revisions, but were exclud-
ed from the analysis. In this study, therefore, a total of 55 hips
were analysed (Fig. 1) in 43 women and 12 men. The patients
had a mean age, at the time of surgery, of 66 (range 34–90)
years. Infected implants were associated with THAs in 32
patients and hemiarthroplasties in 23 patients.
In accordance with published criteria [6, 7, 9–12], one-
stage revision THAwas performed if (1) the patient’s general
condition was good, (2) wound complications were absent, (3)
the pathogen(s) was antibiotic sensitive and (4) the bone
defect requiring reconstruction was small. Two-stage revision
THAwas performed in cases that did not meet the criteria for
one-stage revision THA, but the final decision was made
intraoperatively by the surgeon [14]. All patients received
cemented THAs with custom-mixed ALAC, according to
the reported bacterial sensitivities determined from the pre-
operative aspirates. Over 3.6 g of antibiotic per 40 g of cement
was used in the first stage of two-stage revision THAs, and
1.0–2.0 g of antibiotic per 40 g of cement was used in the
second stage of two-stage revision THAs and in one-stage
revision THAs (Endurance Bone Cement, DePuy Internation-
al, Leeds, UK).
Treatment of periprosthetic hip infection involves thorough
debridement and administration of adequate local and system-
ic antibiotics. Initially, a thorough debridement was per-
formed, using a transgluteal approach, to effect the complete
removal of all implant components, cement, granulation tissue
and necrotic/infected tissues. To ensure a thorough debride-
ment, routine radiographs, computed tomography scans and
radioactive isotopes were used to assess necrotic and infected
tissues. Aspiration and periprosthetic tissue specimens were
sent for microbiology and pathology studies. The hip joint
was exhaustively flushed and then irrigated with hydrogen
peroxide solution and povidone iodine. Subsequently, for one-
stage revision THAs, all instruments, including the light han-
dle, sucker and electrocautery scalpel, and protective clothing
were replaced with fresh, sterile materials. Further, the old
drape was covered with a new one, and new sterile instru-
ments were prepared. Appropriate intravenous systemic anti-
biotic therapy was started and continued for two weeks post-
operatively. Subsequently, oral antibiotic therapy, tailored to
the clinical signs and CRP levels, was administered for a
minimum of three months. In two-stage revision THAs, after
thorough debridement, a handmade rod and beads, including
adequate high-dose ALAC were temporarily placed. Appropri-
ate intravenous systemic antibiotic therapy was initiated and
continued postoperatively for two weeks, followed by oral
antibiotic therapy during the period between the initial debride-
ment and the revision THA. At six to eight weeks after the first
thorough debridement, the clinical signs and CRP levels were
reviewed and a second thorough debridement was performed
prior to the THA; the THA, using ALAC, was then performed.
The postoperative therapy was identical to that used following
one-stage revision THAs. If the debridement failed to control the
infection, the two-stage revision THA procedure was repeated.
All patients underwent weekly follow-up visits for two months,
then at three, six and nine months, and biannually thereafter.
A new scoring system for the preoperative evaluation of
one- and two-stage revision THAs was developed, based on
the six essential variables previously recognised as major risk
factors for infection [6, 7, 9–12]. These included (1) patient’s
general condition, (2) duration of infection and number of
prior operations, (3) present wound complications, (4) the
presence of microorganisms, (5) CRP levels and (6) the ne-
cessity of bone grafting (Fig. 2). Each parameter received 0–2
points, giving a maximum score of 12 points. After the valid-
ity of the new scoring system was confirmed, a retrospective
analysis was performed by two orthopaedic surgeons blinded
to the scoring outcomes.
Prosthesis survival was analysed using the Kaplan-Meier
method, with 95% confidence intervals (CIs); implant remov-
al due to recurrent infection was considered the end point.
Univariate Cox proportional hazards models of the association
between risk factors and implant removal were built. All
independently associated variables were included in the mul-
tivariate Cox analysis. In addition, the first episode of recur-
rent infection was analysed, but further episodes were cen-
sored. The validity of the scoring system was evaluated using
receiver-operating characteristic (ROC) curves. The ROC
analysis was performed using the parameters identified in
the multivariate analysis to define the threshold for implant
removal, facilitating the calculation of sensitivity and speci-
ficity. Prognostic sensitivity was defined as the total number
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of cases divided by the number of implant removals. The
ROC curve was constructed by plotting the sensitivity, on
the vertical axis, and 100 minus the specificity, on the hori-
zontal axis, for a given cut-off point. Using ROC analysis, the
thresholds for the best sensitivity and specificity of the scoring
system were defined, and thereby the most valuable cut-off
point for each score was estimated. A two-way table of the
scores and outcomes was constructed to predict the risk of
recurrence for each score. All data were analysed using one-
way analysis of variance (ANOVA), using SAS version 9.2
(SAS Institute, Cary, NC, USA); a p value <0.05 was consid-
ered significant.
Results
Patient demographic data are shown in Table 1, and the
microorganisms isolated pre- and intraoperatively are shown
in Table 2. Among patients undergoing one-stage revision
THA, 16 of 17 cases were successful, and among patients
undergoing two-stage revision THA, including multiple-stage
revision THA, 33 of 38 cases were successful (Fig. 3). The ten
year survival rate was 94 % (95 % CI 83–100) for one-stage
revision THA and 87 % (95 % CI 76–98) for the two-stage
revision THA.
Significant univariate risk factors for implant removal
due to recurrent infection were general condition [hazard
ratio (HR) 0.13; 95 % CI 0.03–0.51; p=0.003], the pres-
ence of microorganisms (HR 0.42; 95 % CI 0.18–1.00;
p=0.049) and CRP level (HR 0.27; 95 % CI 0.08–0.86;
p=0.027). In the multivariate Cox regression analysis, the
total preoperative score was an independent risk factor for
implant removal due to recurrent infection (HR 0.17;
95 % CI 0.06–0.49; p=0.001). To confirm the validity
of the scoring system, the sensitivity and specificity were
plotted on an ROC curve (area under the curve 0.97; 95 %
CI 0.91–1.00) (Fig. 4a). The sensitivity and specificity, at
a scoring system cut-off of 4 points, were 83 and 100 %,
respectively; the risk of recurrent infection in patients
Fig. 1 Study flow chart
Fig. 2 Pre-operative scoring system
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scoring 4 points was 83 %. The risk of infection recur-
rence is graphically illustrated in Fig. 4b.
The preoperative scores (Fig. 5) for successful cases were
8–12 points for patients undergoing one-stage revision THA
and 5–9 points for those undergoing two-stage revision THA.
In addition, for patients undergoing one-stage revision THA,
the average total pre-operative scores for successful and failed
cases were 9.9 and 6.0, respectively. The average total pre-
operative scores for patients undergoing successful two-stage
revision THAs, multiple-stage revision THAs and failed two-
stage revision THAs were 7.2, 5.8 and 3.6, respectively. There
were significant differences between the mean preoperative
scores of patients undergoing successful one- and two-stage
revision THAs (p<0.05). Among patients undergoing two-
stage revision THAs, there were significant differences in the
mean preoperative scores between the successful and failed
cases (p<0.05).
Discussion
The current consensus, based on algorithms and staging sys-
tems for periprosthetic hip infections [6–10], is that one-stage
revision THA can be performed when required by patient
circumstances. However, a scoring system is not available to
help determine when a one- or two-stage revision THA surgical
strategy is appropriate. We selected individual risk factors,
based on the published criteria [6, 7, 9–12], and attempted to
set up a new scoring system for pre-operative evaluations.
Despite the promise of the novel scoring system described
here, there are some limitations to this study. First, the study
sample size was small, involving only 55 individuals.
Obtaining a large series from a single institution is difficult,
and there have been only five literature reports involving
relatively large patient series (>50 patients) from a single
institution [15–19]. We considered an analysis from a single
Table 1 Patient demographics
One-stage revision THA (n=17) Two-stage revision THA (n=38)
Mean age at time of surgery (years) 69 (52–90) 64 (34–86)
Male to female ratio 5:12 7:31
THA to hemiarthroplasty ratio 11:6 21:17
Mean time from primary procedure to first-stage revision (years) 4 (0.3–12) 4 (0.1–14)
Mean time from first-stage to second-stage revision (weeks) – 8 (5–13)
Mean time from revised THA to final follow-up (years) 6 (0.7–11) 5 (0.7–10)
The values show the mean (range)
THA total hip arthroplasty
Table 2 Microorganisms isolated pre- and intra-operatively






Pseudomonas aeruginosa 0 2
Staphylococcus epidermidis 1 1
MRCNS 0 1
Streptococcus anginosus 0 1
Serratia sp. 0 1
Micrococcus sp. 1 0
Enterococcus sp. 0 1
Peptostreptococcus sp. 0 1
Unknown 6 5
THA total hip arthroplasty, CNS coagulase-negative Staphylococcus, MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-sensitive
Staphylococcus aureus, MSSE methicillin-sensitive Staphylococcus epidermidis, MRSE methicillin-resistant Staphylococcus epidermidis, MRCNS
methicillin-resistant coagulase-negative Staphylococcus
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institution more valuable as studies included in meta-analyses
might include slightly differing techniques performed by sur-
geons. Second, although the validity of the new scoring sys-
tem was confirmed (Fig. 4a), confirmation of the veracity of
each established parameter was not possible. For example,
Wroblewski [12], Elson [15] and Hsieh et al. [20] recom-
mended two-stage revision THAs in cases where bone
grafting was necessary, whereas Rudelli et al. [21] reported
that among 32 patients, including those with sinus tracts, the
recurrence rate was 94% for one-stage revision THA. Among
patients with sinus tracts, Raut et al. [22] and Ure et al. [23]
reported that infection was controlled in 90 and 100 % of
patients, respectively. Furthermore, in our study, we did not
explore other potential variables such as implant loosening,
polymicrobial infection and haematogenous infection for the
scoring system. Third, some patients, not undergoing implant
removal, may have actually had recurrent infections.
However, if these cases were not diagnosed as being infected,
according to the working definition, they were not considered
recurrent infections. Determination of the necessity of surgical
treatment is important, and we defined a failure as an implant
removal due to recurrent infection. In addition, the duration of
antibiotic therapy after reimplantation during a two-stage re-
vision THAmay not be universally consistent. Zimmerli et al.
[24] suggested that, in two-stage revision THAs, if intraoper-
ative specimen cultures remain negative, antimicrobial treat-
ment may be discontinued after six weeks; otherwise, therapy
should continue for three months. However, our duration was
not congruent with international benchmarks.
Jackson and Schmalzried [11] conducted an infection con-
trol analysis of 1,299 cases of THA from 12 studies to deter-
mine the factors associated with successful patient outcomes.
They suggested that cementless implants may be contraindi-
cated in patients requiring one-stage revision THAs. In our
Fig. 3 Radiographs of a 75-year-
old woman who underwent two-
stage revision THA (scoring sys-
tem, 7 points). a Combined defi-
ciencies, acetabular defect. b
ALAC beads seven weeks after
the first-stage surgery. c Five
years after reimplantation with
allograft reconstruction and a
metal ring
Fig. 4 a ROC curves. b
Percentage risk of recurrence for
each score
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study, the ten year survival rates were 94 and 87 % for one-
and two-stage revision THAs, respectively, although selection
bias may undermine the validity of this direct comparison.
Consequently, one-stage revision THAs involving ALAC
gave promising results because of their advantages for the
treatment and prevention of infection. According to previous
reports (Table 3), some surgeons routinely perform one-stage
revision THAs, with infection control rates in six studies
reported to be 77–100 % [1, 2, 12, 22, 23, 25]. Others,
including our study, selected one-stage revision THA depend-
ing on patient requirements and showed infection control rates
of 76–100 % in the eight studies [13, 15–19, 26]. These rates
were similar to those reported in studies only performing one-
stage revision THAs. The indications for one-stage revision
THAs are shown in Table 3, but there are few reports describ-
ing the use of definite algorithms [14, 19]. Oussedik et al. [18]
suggested that a direct comparison between one- and two-
stage revision THA is difficult, given the non-randomised
nature of such studies, but that including those patients treated
by two-stage revision THA can provide an estimate of the
proportion of cases that might be suitable for one-stage revi-
sion THA. According to the pre-operative scoring system,
there were significant differences between the scores corre-
sponding to successful one- and two-stage revision THAs;
Fig. 5 Total preoperative scores
for patients undergoing one- and
two-stage THA
Table 3 Recently published studies reporting relatively large series of one-stage revision THAs from a single institution
First author Year published One-stage revision THA Two-stage revision THA Indication
n Infection control (%) n Infection control (%)
Buchholz [13] 1981 667 77 – No selection
Miley [25] 1982 47 87 – No selection
Wroblewski [12] 1986 102 91 – No selection
Raut [22] 1994 57 86 – No selection
Ure [23] 1998 20 100 – No selection
Callaghan [2] 1999 24 92 – No selection
Sanzén [19] 1988 72 76 30 75 GC, BG
Hope [16] 1989 72 88 19 100 PO, MO, BG
Elson [15] 1993 235 88 61 97 Not described
Garvin [26] 1994 10 90 30 97 DI, WC, MO
Klouche [17] 2000 38 100 46 98 DI, MO, BG
Giulieri [13] 2004 16 94 31 90 Zimmerli’s algorithm [10]
Oussedik [18] 2010 11 100 39 95 Haddad’s protocol [6]
Our study 2014 17 94 38 87 GC, DI, PO, WC, MO, CRP, BG
THA total hip arthroplasty, GC general condition, BG bone grafting, PO past operations, MO microorganisms, DI duration of infection, WC wound
complication, CRP C-reactive protein
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one-stage revision THA was recommended in cases scoring
more than 9 points (Fig. 5). In contrast, the risk of recurrent
infection in patients scoring 4 points was 83 % (Fig. 4).
In conclusion, the novel preoperative scoring system de-
scribed here was useful for determining the management of
periprosthetic hip infections. One-stage revision THA is rec-
ommended for patients scoring more than 9 points, and other
options should be considered for patients scoring 4 or fewer
points in order to minimise the risk of recurrent infection.
Additionally, one-stage revision THAs may be possible for
cases scoring 7 or 8 points. To fully validate this novel scoring
system, a prospective study of the system in a multicentre trial
is required.
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